Research

COMPARATIVE EVALUATION OF ANTIOXIDANT POTENTIAL OF EZENUS AND OTHER HERBAL PRODUCTS :

An In Vitro Study by M. Chaudhary and V. Naithani published in World Journal of Pharmacy and Pharmaceutical Sciences

Comparator product details of the Ezenus efficacy study

• EZENUS (M) has the highest Polyphenol, Flavanoid and Thiol i.e. antioxidant content.
• EZENUS (M) is the highest in inhibiting Lipid peroxidation and lowering Malondialdehyde content thus demonstrating that it can reduce oxidative stress.
• EZENUS (M) is most potent in scavenging Superoxide, DPPH and Hydroxyl radicals which are also known as free radicals that damage cells.

EZENUS CLINICAL STUDIES

A DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED STUDY TO ASSESS THE ANTIOXIDANT ACTIVITY OF DIETARY SUPPLEMENT EZENUS IN ADULT HEALTHY SUBJECTS (240)*

*The Clinical Trial was carried out for a period of 30 days. Female subjects were not a part of smoking/alcoholic subject group.

The Clinical Trial was not done on pregnant/lactating women.

• EZENUS could bring 35 % reduction in MDA level for non-smoking population and 45 % reduction in MDA levels after 30 days for smoking male population.
• EZENUS could bring upto 35 % reduction F2-Isoprostane levels occurring in the body by virtue of its antioxidant properties for both smoking and non-smoking population.
• EZENUS could bring upto 50 % elevation in TAC (TOTAL ANTIOXIDANT CAPACITY) levels after 30 days for smoking population.